Developer of artificial intelligence-based drug discovery platform designed to unlock small and noisy datasets. The company's platform uses bioinformatics and artificial intelligence to optimize the development of drugs through predictive analytics and work with the small and noisy datasets characteristic of low-throughput compound screens and late-stage lead optimization, enabling pharmaceutical companies to reduce the time, design, and optimize novel ligands against a broad range of precision medicine targets.